Qiagen Continues Asia, MDx Investment Trend With Newly Formed Singapore JV | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Continuing its expansion in Asia and its focus on molecular diagnostics development, Qiagen is forming a joint venture with Bio*One Capital in Singapore focused on developing molecular diagnostic assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.